MTAP and coronary artery disorder: This integrative strategy enabled us to map an atlas of disease-associated variants to functional enhancers in disease-relevant cell types, connect enhancers to target genes, and nominate a causal effector gene—MTAP—mediating vascular remodeling and CAD susceptibility.